News

Every three minutes, a child succumbs to tuberculosis (TB), a curable disease if diagnosed in time. Can the new treatment decision algorithms, one of ...

In a recent study carried out in Niger and funded by EDCTP*, Epicentre assessed the impact and feasibility of mass vaccination campaigns with a single...

Committed to reducing its carbon footprint by 50% by 2030, Epicentre has already made significant progress, significantly reducing emissions linked to...

Too many children with TB are neither tested nor treated, with many countries failing at the first hurdle: updating policy guidelines in line with WHO...

The GASTROSAM study seeks to demonstrate that a new approach to treating children suffering from severe malnutrition and dehydration is not only possi...

Launched in 2021 and funded by Wellcome, UK AID and the Foreign and Commonwealth Development Office, a study is assessing the impact of preventive cho...

Published in The Lancet Infectious Diseases, a study has revealed that 10 days after vaccination, the risk of developing Ebola is reduced by 84 per ce...

A new survey carried out by Epicentre among displaced people in four camps around Goma in Democratic Republic of Congo (DRC), shows alarming rates of ...

A study coordinated by Epicentre in collaboration with Barcelona's Hospital del Mar and Médecins Sans Frontières (MSF) Spain, shows that thoracic ultr...

Nearly 20 per cent of Rohingya refugees tested in the camps of Cox's Bazar, Bangladesh, have an active hepatitis C infection. This is the finding of a...